SEC Company Filings


Filing DateForm (Link to docs.)DescriptionDownload
8/14/202010-QQuarterly report [Sections 13 or 15(d)]PDF
7/9/20208-KCurrent report, items 5.02 and 8.01PDF
5/21/20208-KCurrent report, item 5.02PDF
5/7/202010-QQuarterly report [Sections 13 or 15(d)]PDF
5/6/20208-KCurrent report, items 5.02, 7.01, and 9.01PDF
4/24/20208-KCurrent report, item 5.07PDF
4/17/2020DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialPDF
4/15/20208-KCurrent report, item 3.01PDF
3/30/2020Pre 14AOther preliminary proxy statementsPDF
3/17/2020S-8Securities to be offered to employees in employee benefit plansPDF
3/17/202010-KAnnual report [Section 13 and 15(d), not S-K Item 405]PDF
3/16/20208-KCurrent report, item 8.01PDF
2/10/20208-KCurrent report, items 5.02 and 8.01PDF
2/4/20208-KCurrent report, items 2.05, 7.01, and 9.01PDF
1/31/20208-KCurrent report, item 8.01PDF
1/10/20208-KCurrent report, item 8.01PDF
1/2/20208-KCurrent report, items 5.02 and 8.01PDF
11/21/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
11/15/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
11/12/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
10/28/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
9/23/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
8/13/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
8/6/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
7/22/2019S-8Securities to be offered to employees in employee benefit plansPDF
7/8/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
6/18/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
5/28/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
5/22/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
4/24/201920-F/A[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]PDF
3/25/201920-KAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]PDF
3/14/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
3/12/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
2/14/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
2/13/2019424B4Prospectus [Rule 424(b)(4)]PDF
2/12/20196-KReport of foreign issuer [Rules 13a-16 and 15d-16]PDF
2/11/2019F-1/A[Amend] Registration statement for certain foreign private issuersPDF
2/8/20198-A12BRegistration of securities [Section 12(b)]PDF
2/8/2019F-1/A[Amend] Registration statement for certain foreign private issuersPDF
2/7/2019F-1/A[Amend] Registration statement for certain foreign private issuersPDF
1/30/2019F-1/A[Amend] Registration statement for certain foreign private issuersPDF
1/7/2019F-1Registration statement for certain foreign private issuers PDF

Anchiano Therapeutics Ltd. CIK#: 0001534248